Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in CANC
50.0%
% of CANC's 48 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.4% | 2.9% | 2.4% |
|
ABBVIE INC | 2.4% | 2.1% | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 2.0% | 2.9% | 2.0% |
|
EXELIXIS INC | 1.9% | 4.0% | 1.9% |
|
GILEAD SCIENCES INC | 2.4% | 1.9% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CANC
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
NATERA INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
BIOGEN IDEC INC | 2.5% |
|
EXACT SCIENCES CORP | 2.3% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
|
MODERNA, INC. | 2.2% |
XBI Underweight Relative to CANC
|
ELI LILLY & CO | -5.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.2% |
|
BRISTOL-MYERS SQUIBB CO | -4.5% |
 |
ASTRAZENECA PLC | -4.3% |
|
NOVARTIS AG | -4.2% |
|
REVOLUTION MEDICINES, INC. | -4.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.7% |
 |
GENMAB A/S SPONSORED ADR | -3.1% |
 |
MERUS N.V. | -3.1% |
 |
DAIICHI SANKYO CO LTD | -3.0% |